Evidence map›Paper›PMID 42708409›Full record

ArticleNucleic acids research2026

Enhancing prediction accuracy for enzyme activity engineering through sequence co-evolution and epistatic relationship modeling.

Da Neub Kim, Hyeongseop Kim, Donghyo Kim, Gyoo Yeol Jung, Sanguk Kim, Myung Hyun Noh

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Da Neub KimSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, Gyeongbuk, 37673, Korea.
Hyeongseop KimSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, Gyeongbuk, 37673, Korea.ORCID 0009-0002-8810-8915
Donghyo KimDepartment of Chemical Engineering, Pohang University of Science and Technology, Pohang, Gyeongbuk, 37673, Korea.ORCID 0000-0002-8097-3675
Gyoo Yeol JungSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, Gyeongbuk, 37673, Korea.ORCID 0000-0002-9742-3207
Sanguk KimSchool of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology, Pohang, Gyeongbuk, 37673, Korea.ORCID 0000-0002-3449-3814
Myung Hyun NohCenter for Bio-based Chemistry, Korea Research Institute of Chemical Technology, Ulsan, 44429, Korea.ORCID 0000-0001-9045-7968

Funding

Korea Research Institute of Bioscience and Biotechnology Research Initiative Program KGM1302612Ministry of Science and ICTNational Research Foundation of Korea 2020R1A6A1A03047902National Research Foundation of Korea RS-2024-00400033National Research Foundation of Korea RS-2024-00453085National Research Foundation of Korea RS-2025-16070008
6 · The paper itself

Abstract

Conventional enzyme engineering strategies, such as directed evolution with structure-based analysis, are limited by laborious workflows and by the need to screen extensive enzyme libraries. Computational models based on multiple sequence alignment, such as SCANEER, have streamlined these engineering strategies, enabling the successful prediction of single-site mutations that enhance enzyme activity. However, when combining predicted mutations to improve enzyme performance or expand mutational space, such approaches often fail due to epistatic interactions among amino acid residues, which can lead to complex, non-additive effects. Here, we present epiSCANEER, an extended computational framework that incorporates co-evolutionary dependencies reflecting residue-level epistatic effects to identify mutation combinations with a higher likelihood of enhancing enzyme activity. By evaluating amino acid pairs at co-evolved positions across homologous sequences, epiSCANEER prioritizes mutation combinations with high evolutionary compatibility, significantly narrowing the combinatorial search space to variants more likely to exhibit activity-enhancing effects. Experimental validation demonstrated a 76% success rate for epiSCANEER prediction, compared to 30% and 38% for single-site predictions and combinatorial approaches of single-site mutants, respectively. This novel method obviates the need to construct single-mutation libraries, significantly reducing labor and costs while improving success rates. epiSCANEER has been developed as a web-server that enables researchers to access tools for rational enzyme optimization.

Indexed as

EnzymesEpistasis, GeneticProtein EngineeringSoftwareDirected Molecular EvolutionEvolution, MolecularMutationPrediction AlgorithmsEnzymes

Identifiers

PMID42708409
PMCPMC13551031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.